1. Home
  2. Clinical Topics
  3. FDA releases recommendations to reduce risk of Zika virus blood transmission
Clinical TopicsDrugs and DevicesWeb Exclusives

FDA releases recommendations to reduce risk of Zika virus blood transmission

Share

On Feb. 17, the Food and Drug Administration (FDA) issues recommendations to reduce the risk of transmission of the Zika virus through blood transfusion. The FDA recommends deferral of individuals from donating blood if they have been to areas with active Zika virus transmission, potentially have been exposed to the virus, or have had a confirmed Zika virus infection. Read more.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts